Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Edward A. Mule currently holds 3,449,885 shares of K-V Pharmaceutical Co (NONE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward A. Mule has been a net seller of NONE stock. They have purchased $68.5M and sold $472.0M worth of shares.
Edward A. Mule's most recent insider trade was on Dec 2, 2025, when they sold 45,546 shares at $219.56 per share.
Edward A. Mule serves as Executive at K-V Pharmaceutical Co (NONE). They have executed 150 insider transactions totaling $540.5M over their tenure at the company.
Edward A. Mule holds the position of Executive at K-V Pharmaceutical Co, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Edward A. Mule has shown a selling trading pattern, with $68.5M in total purchases and $472.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Edward A. Mule was on Jun 26, 2023, when they sold $136.5M worth of GPOR shares. This transaction involved 1,436,814 shares at $95.00 per share.
Edward A. Mule currently owns 3,449,885 shares of K-V Pharmaceutical Co (NONE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Edward A. Mule's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Edward A. Mule has 150 Form 4 filings on record as an insider at K-V Pharmaceutical Co.
Set alerts for Edward A. Mule and 40,000+ other insiders.